Investigational treatment for patients currently diagnosed with asthma, no other significant pulmonary disease, having used their albuterol inhaler at least twice in the two weeks prior to screening/enrollment.
Who’s eligible?
- Men and Women 12 years old and above
- One-year long commitment with telehealth visits only
- Patient compensation provided for time and participation
If you are eligible and enroll, you will receive all study-related care at no cost. You will also receive monitoring by a research doctor.
For additional details or if you have questions, please call (425) 225-2780 or email clinicalresearch@wwmedgroup.com.